Cecil Sales

All Posts

  • Grab a Beer and Relax

    By Cecil Sales - December 20, 2012 | Tickers: BUD, PDRDY.PK, SBMRY

    The adult beverage trade has seen a good year in 2012. Stocks of companies such as SABMiller (NASDAQOTH: SBMRY)Pernod Ricard (NASDAQOTH: PDRDY) and Anheuser-Busch InBev (NYSE: BUD) have done well. If you look at the stock price, it seems like everyone is having a drink. So let us take a look at these three companies and which one of them will be a good investment.

    Arguments for SABMiller

    SABMiller more »

  • Beer Bellies Increasing? Oh Yes They Are!

    By Cecil Sales - December 18, 2012 | Tickers: HEINY

    It's been quiet sometime since I've noticed an increase in the number of not so good looking bellies day by day. This observation is not just around me but I've been noticing them in various TV shows and news reports of people around the world. All of these thoughts came into perspective the minute I noticed the growth of the three largest brewery companies. Let’s take more »

  • 3 Stocks Facing a Short Squeeze

    By Cecil Sales - December 17, 2012 | Tickers: ARUN, FSLR, JCP

    I scoured the countryside to find three stocks that are facing battle between insider trading and short sellers. Short selling is the selling of a stock that the seller doesn't own. When you short sell a stock, your broker will lend it to you. The stock will come from the brokerage's own inventory, from another one of the firm's customers, or from another brokerage firm. The shares more »

  • 3 Biotechs Moving Higher

    By Cecil Sales - December 17, 2012 | Tickers: CTIX, CLDX, INFI

    It has been a mixed year for the biotech industry with some moving up and some losing nearly 80% of their value. It’s a sector not exactly fraught with uncertainty, but has a big share of it nonetheless. For example, sometimes negative movement can be thanks to disappointing ends to FDA trials which are difficult to predict. After good trial data, often the risk profile declines as investors perceived more »

  • Natural Gas – Here’s Where It’s At

    By Cecil Sales - December 16, 2012 | Tickers: LNG, XOM, SRE

    It is quite clear now that the export of LNG will only help to boost the American economy. Natural Gas in the United States is fairly cheap and companies in this space are going to benefit tremendously with the opening up of borders, in a manner of speaking.

    Cheniere Energy Partners

    Cheniere Energy (NYSEMKT: LNG), a Delaware corporation, is a Houston-based energy company primarily engaged in LNG-related businesses. The company more »

  • Back To Basics

    By Cecil Sales - December 16, 2012 | Tickers: AGU, CF, POT

    In some senses, going back to the basics is a good way to invest. Look at companies that will still have a role to play if the world goes back to a primitive age or something like that. Construction, agriculture and healthcare will still be fairly intact when compared to sectors like fast food and beverages. So with that in mind, I’ve found a few companies in a sector more »

  • 3 Stocks With Significant Upside Potential

    By Cecil Sales - December 14, 2012 | Tickers: AKS, ALU, NOK

    In my research for new stocks, I found a bunch of companies that show significant potential to grow in terms of their earnings. EPS, in each of these companies, are expected to grow substantially over the next 5 years.

    AK Steel Holding Corporation

    AK Steel Holding Corporation (NYSE: AKS) is an integrated producer of flat-rolled carbon, stainless and electrical steels and tubular products through its wholly owned subsidiary, AK Steel more »

  • Accurate Time for Acura

    By Cecil Sales - December 13, 2012 | Tickers: ACUR, JNJ, PFE | Editor's Choice

    Acura Pharmaceuticals (NASDAQ: ACUR) is a pharmaceutical company with a difference. On the company’s website the description makes it fairly clear why it is different.  The company is a specialty pharmaceutical company developing and commercializing tamper-resistant products to combat medication abuse and misuse. Acura attempts to achieve these goals through its proprietary “Aversion” and “Impede” technologies. These technologies involve the company adding inactive pharmaceuticals to a drug that render more »

  • Three Good Dividend Stocks

    By Cecil Sales - December 13, 2012 | Tickers: COH, GME, KMP

    I’m a big advocate of dividend stocks, because I like the consistent additional income they provide. I think the regular payments add a different dimension to stocks. Even if the value of the stock reduces significantly in the long term, you would hopefully have made up the loss (and more) thanks to dividend payments.  So without further ado, let’s take a look at three companies that are fairly more »

  •  A Basic Need of the Hour

    By Cecil Sales - December 12, 2012 | Tickers: MTZ, PIKE

    In the wake of Sandy many homeowners and businesses remained without power for weeks. This clearly brought to notice the requirement for a good power grid across the country. Power grid construction companies will benefit from the added revenue that they obtain directly from fixing the damage caused by Sandy and will benefit indirectly as demand across the industry will be greatly increased and thus capacity will be strained.

    The more »

  • The Social Network Rush

    By Cecil Sales - December 12, 2012 | Tickers: CSCO, FB, MSFT

    There seems to be a social network rush going on, fairly similar to the gold rush experienced in California many years ago. A large number of companies are moving in to corner the social network market or create their own social network. This is a slightly confusing move, if I am to be perfectly honest, but let’s take a look at some networks and how they may or may more »

  • 3 Undervalued Dividend Stocks

    By Cecil Sales - December 12, 2012 | Tickers: HPT, POR, PL

    Investing in undervalued companies is an excellent idea. But the real challenge is to find a company that’s undervalued, not only based on their numbers, but also because their intrinsic value is ignored by investors and the Street. So I’ve embarked on a journey to find 3 companies whose stocks are undervalued and have a good dividend policy.

    Protective Life Corporation

    Protective Life Corporation (NYSE: PL) is a more »

  • What Now For Zynga?

    By Cecil Sales - December 12, 2012 | Tickers: EA, FB, ZNGA

    For most of us Zynga (NASDAQ: ZNGA) is generally spoken of in the same sentence as Facebook (NASDAQ: FB). The maker of the popular title Farmville has recently amended its terms of agreement with the social media giant. According to the new agreement, Facebook will no longer have exclusive rights to Zynga’s titles and are allowed to make their own gaming titles starting in March 2013.

    Zynga will no more »

  • For Your Eyes Only..

    By Cecil Sales - December 11, 2012 | Tickers: APKT, DLB

    If you love sound fundamentals, that is. Here is a list of companies whose quick ratio and price to earnings ratio is greater than 5. Most of these companies have little or no debt which is a very alluring factor in case of an adverse environment.

    Dolby

    Dolby Laboratories (NYSE: DLB) is in the Technology - Diversified Electronics sub-industry with a $3.47B market cap and a quick ratio of 6 more »

  • Is Intel Still a Safe Bet?

    By Cecil Sales - December 10, 2012 | Tickers: AMD, ARMH, INTC

    In the wake of a few incidents an average investor might think that Intel (NASDAQ: INTC) has started losing its sheen in the market. But I beg to differ! And with this article I hope to convince you.

    Before we dive into Intel and its strengths, it would make sense to understand the fear surrounding the stock. The early retirement plans of Intel CEO Paul Otellini are surely one of more »

  • The Changing World Of Obamacare

    By Cecil Sales - December 10, 2012 | Tickers: HCA, HMA, LPNT

    Obamacare favors big hospitals. Big Hospital was one of the powerful lobbies, along with Big Pharma and Big Insurance that supported Obamacare to become a law. Big Hospital lobbied hard for Obamacare's insurance mandate and for steering more business to big institutions.

    President Barack Obama's re-election means his overhaul of the U.S. health-care system, opposed by most Republicans, will move ahead in all 50 states, with or more »

  • Is It Time To Start Worrying About Apple?

    By Cecil Sales - December 6, 2012 | Tickers: AAPL, GOOG, NOK

    The apple of many investors’ eyes (pun intended) has started to falter of late. Apple (NASDAQ: AAPL) shares are off another 4 percent today, and the company has lost a fifth of its market value since shares peaked in mid-September. 

    So is this a worrisome sign for Apple investors? Let’s take a look and find out.

    The Phone Wars

    I have mentioned earlier the study from IDC claiming that more »

  • Try These Tech Stocks in 2013

    By Cecil Sales - December 6, 2012 | Tickers: AMZN, EMC, QCOM

    With the new year coming up, it’s prudent to take a look at some companies that are worth paying attention to. Of course, if you are a long term investor, you probably already have your positions for certain stocks. However, there’s never really a bad time to expand your portfolio, so you may still benefit from this list.

    Amazon

    Amazon’s (NASDAQ: AMZN) primary line of business is more »

  • A Name for the Value Investor

    By Cecil Sales - December 4, 2012 | Tickers: MCD, SBUX, YUM

    Value investors always hope that great names in the market will come down drastically. McDonald's (NYSE: MCD) is a business that I believe has an extremely wide-moat, and produces very high returns on capital. Over the last decade, few companies have innovated and executed as well as McDonald's, and while I don't believe the next decade will be as fruitful as the last in terms of margin more »

  • Nokia and RIM: Dead or Alive?

    By Cecil Sales - December 3, 2012 | Tickers: BBRY, MSFT, NOK

    Google owns a large portion of the mobile phone market, and though Apple doesn't rank very high when it came to market share, it is still a formidable powerhouse because it synced hardware and software excellence perfectly. In some sense, each of these companies has a virtual monopoly in some way or the other. So should they be worried about a few other companies that could chip away at more »

  • Page 1 of 5